Market Overview

CLASS ACTION UPDATE for RMTI and HMNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Share:

NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.


Rockwell Medical, Inc. (NASDAQ:RMTI)
Class Period:
March 16, 2018 - June 26, 2018
Lead Plaintiff Deadline: September 25, 2018
Join the action: http://www.zlk.com/pslra-d/rockwell-medical-inc?wire=3

The lawsuit alleges: Rockwell Medical, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) Rockwell was aware that The Centers for Medicare and Medicaid Services will not pursue Rockwell's proposal for separate reimbursement for the drug Triferic; (2) the estimated reserves in the first quarter 2018 10-Q are misstated; (3) there was a material weakness in Rockwell's internal controls over financial reporting; (4) consequently, Rockwell's internal controls over financial reporting were ineffective during the Class Period; (5) Defendant Chioini withheld material information regarding Triferic from Rockwell's auditor, corporate counsel and five independent directors of the Board; and (6) as a result, Defendants' statements about the Company's business, operations and prospects were materially false and misleading and/or lacked reasonable bases at all relevant times.

To learn more about the RMTI class action contact jlevi@levikorsinsky.com.

Helios and Matheson Analytics Inc. (NASDAQCM: HMNY)
Class Period:
August 15, 2017 - July 26, 2018
Lead Plaintiff Deadline: October 1, 2018
Join the action: http://www.zlk.com/pslra-d/helios-and-matheson-analytics-inc?wire=3

The lawsuit alleges: Helios and Matheson Analytics Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Helios was touting MoviePass' valuation and path to profitability; (ii) MoviePass' business model was not sustainable, (iii) consequently, Helios would run out of cash, (iv) Defendants' actions were only reducing shareholder value, and (v) as a result of the foregoing, Defendants' statements about Helios' business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

To learn more about the HMNY class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.


Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.


CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Primary Logo

View Comments and Join the Discussion!